ID   KAT5_HUMAN              Reviewed;         513 AA.
AC   Q92993; B4E3C7; C9JL99; O95624; Q13430; Q17RW5; Q561W3; Q6GSE8;
AC   Q9BWK7;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2003, sequence version 2.
DT   10-MAY-2017, entry version 185.
DE   RecName: Full=Histone acetyltransferase KAT5;
DE            EC=2.3.1.48 {ECO:0000269|PubMed:10096020, ECO:0000269|PubMed:12468530};
DE   AltName: Full=60 kDa Tat-interactive protein;
DE            Short=Tip60;
DE   AltName: Full=Histone acetyltransferase HTATIP;
DE            Short=HIV-1 Tat interactive protein;
DE   AltName: Full=Lysine acetyltransferase 5;
DE   AltName: Full=cPLA(2)-interacting protein;
GN   Name=KAT5; Synonyms=HTATIP, TIP60;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INTERACTION WITH HIV-1
RP   TAT.
RC   TISSUE=Lymphoblast;
RX   PubMed=8607265; DOI=10.1006/viro.1996.0071;
RA   Kamine J., Elangovan B., Subramanian T., Coleman D., Chinnadurai G.;
RT   "Identification of a cellular protein that specifically interacts with
RT   the essential cysteine region of the HIV-1 Tat transactivator.";
RL   Virology 216:357-366(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), INTERACTION WITH PLA2G4A, AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Fibroblast, and Placenta;
RX   PubMed=11416127; DOI=10.1128/MCB.21.14.4470-4481.2001;
RA   Sheridan A.M., Force T., Yoon H.J., O'Leary E., Choukroun G.,
RA   Taheri M.R., Bonventre J.V.;
RT   "PLIP, a novel splice variant of Tip60, interacts with group IV
RT   cytosolic phospholipase A(2), induces apoptosis, and potentiates
RT   prostaglandin production.";
RL   Mol. Cell. Biol. 21:4470-4481(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RX   PubMed=12801643; DOI=10.1016/S0378-1119(03)00547-X;
RA   Legube G., Trouche D.;
RT   "Identification of a larger form of the histone acetyl transferase
RT   Tip60.";
RL   Gene 310:161-168(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Cervix, Liver, Placenta, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 19-35; 150-177 AND 297-307, IDENTIFICATION IN NUA4
RP   COMPLEX, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=12963728; DOI=10.1074/jbc.C300389200;
RA   Cai Y., Jin J., Tomomori-Sato C., Sato S., Sorokina I., Parmely T.J.,
RA   Conaway R.C., Conaway J.W.;
RT   "Identification of new subunits of the multiprotein mammalian
RT   TRRAP/TIP60-containing histone acetyltransferase complex.";
RL   J. Biol. Chem. 278:42733-42736(2003).
RN   [10]
RP   CATALYTIC ACTIVITY IN VITRO.
RX   PubMed=10096020; DOI=10.1046/j.1365-2443.1998.00229.x;
RA   Kimura A., Horikoshi M.;
RT   "Tip60 acetylates six lysines of a specific class in core histones in
RT   vitro.";
RL   Genes Cells 3:789-800(1998).
RN   [11]
RP   IDENTIFICATION IN THE NUA4 COMPLEX, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=10966108; DOI=10.1016/S0092-8674(00)00051-9;
RA   Ikura T., Ogryzko V.V., Grigoriev M., Groisman R., Wang J.,
RA   Horikoshi M., Scully R., Qin J., Nakatani Y.;
RT   "Involvement of the TIP60 histone acetylase complex in DNA repair and
RT   apoptosis.";
RL   Cell 102:463-473(2000).
RN   [12]
RP   INTERACTION WITH EDNRA.
RX   PubMed=11262386; DOI=10.1074/jbc.C000909200;
RA   Lee H.-J., Chun M., Kandror K.V.;
RT   "Tip60 and HDAC7 interact with the endothelin receptor a and may be
RT   involved in downstream signaling.";
RL   J. Biol. Chem. 276:16597-16600(2001).
RN   [13]
RP   UBIQUITINATION.
RX   PubMed=11927554; DOI=10.1093/emboj/21.7.1704;
RA   Legube G., Linares L.K., Lemercier C., Scheffner M., Khochbin S.,
RA   Trouche D.;
RT   "Tip60 is targeted to proteasome-mediated degradation by Mdm2 and
RT   accumulates after UV irradiation.";
RL   EMBO J. 21:1704-1712(2002).
RN   [14]
RP   ROLE IN MYC-DEPENDENT TRANSCRIPTION.
RX   PubMed=12776177; DOI=10.1038/sj.embor.embor861;
RA   Frank S.R., Parisi T., Taubert S., Fernandez P., Fuchs M., Chan H.M.,
RA   Livingston D.M., Amati B.;
RT   "MYC recruits the TIP60 histone acetyltransferase complex to
RT   chromatin.";
RL   EMBO Rep. 4:575-580(2003).
RN   [15]
RP   PHOSPHORYLATION AT SER-86 AND SER-90, MUTAGENESIS OF SER-86; SER-90;
RP   LEU-254; LEU-257 AND GLY-380, AND CATALYTIC ACTIVITY.
RX   PubMed=12468530; DOI=10.1074/jbc.M211811200;
RA   Lemercier C., Legube G., Caron C., Louwagie M., Garin J., Trouche D.,
RA   Khochbin S.;
RT   "Tip60 acetyltransferase activity is controlled by phosphorylation.";
RL   J. Biol. Chem. 278:4713-4718(2003).
RN   [16]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH HDAC7.
RX   PubMed=12551922; DOI=10.1074/jbc.M210816200;
RA   Xiao H., Chung J., Kao H.-Y., Yang Y.-C.;
RT   "Tip60 is a co-repressor for STAT3.";
RL   J. Biol. Chem. 278:11197-11204(2003).
RN   [17]
RP   REVIEW ON NUA4 COMPLEX.
RX   PubMed=15196461; DOI=10.1016/j.gde.2004.02.009;
RA   Doyon Y., Cote J.;
RT   "The highly conserved and multifunctional NuA4 HAT complex.";
RL   Curr. Opin. Genet. Dev. 14:147-154(2004).
RN   [18]
RP   ROLE IN TP53-DEPENDENT TRANSCRIPTION.
RX   PubMed=15310756; DOI=10.1074/jbc.M407478200;
RA   Legube G., Linares L.K., Tyteca S., Caron C., Scheffner M.,
RA   Chevillard-Briet M., Trouche D.;
RT   "Role of the histone acetyl transferase Tip60 in the p53 pathway.";
RL   J. Biol. Chem. 279:44825-44833(2004).
RN   [19]
RP   INTERACTION WITH JADE1.
RX   PubMed=15502158; DOI=10.1074/jbc.M410487200;
RA   Panchenko M.V., Zhou M.I., Cohen H.T.;
RT   "von Hippel-Lindau partner Jade-1 is a transcriptional co-activator
RT   associated with histone acetyltransferase activity.";
RL   J. Biol. Chem. 279:56032-56041(2004).
RN   [20]
RP   FUNCTION, IDENTIFICATION BY MASS SPECTROMETRY, AND IDENTIFICATION IN
RP   THE NUA4 COMPLEX.
RX   PubMed=14966270; DOI=10.1128/MCB.24.5.1884-1896.2004;
RA   Doyon Y., Selleck W., Lane W.S., Tan S., Cote J.;
RT   "Structural and functional conservation of the NuA4 histone
RT   acetyltransferase complex from yeast to humans.";
RL   Mol. Cell. Biol. 24:1884-1896(2004).
RN   [21]
RP   ROLE IN E2F1-DEPENDENT TRANSCRIPTION.
RX   PubMed=15121871; DOI=10.1128/MCB.24.10.4546-4556.2004;
RA   Taubert S., Gorrini C., Frank S.R., Parisi T., Fuchs M., Chan H.M.,
RA   Livingston D.M., Amati B.;
RT   "E2F-dependent histone acetylation and recruitment of the Tip60
RT   acetyltransferase complex to chromatin in late G1.";
RL   Mol. Cell. Biol. 24:4546-4556(2004).
RN   [22]
RP   ROLE IN TP53-DEPENDENT TRANSCRIPTION.
RX   PubMed=15042092; DOI=10.1038/nature02371;
RA   Berns K., Hijmans E.M., Mullenders J., Brummelkamp T.R., Velds A.,
RA   Heimerikx M., Kerkhoven R.M., Madiredjo M., Nijkamp W., Weigelt B.,
RA   Agami R., Ge W., Cavet G., Linsley P.S., Beijersbergen R.L.,
RA   Bernards R.;
RT   "A large-scale RNAi screen in human cells identifies new components of
RT   the p53 pathway.";
RL   Nature 428:431-437(2004).
RN   [23]
RP   INTERACTION WITH HIV-1 TAT.
RX   PubMed=16001085; DOI=10.1038/sj.emboj.7600734;
RA   Col E., Caron C., Chable-Bessia C., Legube G., Gazzeri S., Komatsu Y.,
RA   Yoshida M., Benkirane M., Trouche D., Khochbin S.;
RT   "HIV-1 Tat targets Tip60 to impair the apoptotic cell response to
RT   genotoxic stresses.";
RL   EMBO J. 24:2634-2645(2005).
RN   [24]
RP   INTERACTION WITH ATM, AND FUNCTION.
RX   PubMed=16141325; DOI=10.1073/pnas.0504211102;
RA   Sun Y., Jiang X., Chen S., Fernandes N., Price B.D.;
RT   "A role for the Tip60 histone acetyltransferase in the acetylation and
RT   activation of ATM.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:13182-13187(2005).
RN   [25]
RP   IDENTIFICATION IN A COMPLEX WITH HINT1.
RX   PubMed=16835243; DOI=10.1074/jbc.M513452200;
RA   Weiske J., Huber O.;
RT   "The histidine triad protein Hint1 triggers apoptosis independent of
RT   its enzymatic activity.";
RL   J. Biol. Chem. 281:27356-27366(2006).
RN   [26]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=16387653; DOI=10.1016/j.molcel.2005.12.007;
RA   Doyon Y., Cayrou C., Ullah M., Landry A.-J., Cote V., Selleck W.,
RA   Lane W.S., Tan S., Yang X.-J., Cote J.;
RT   "ING tumor suppressor proteins are critical regulators of chromatin
RT   acetylation required for genome expression and perpetuation.";
RL   Mol. Cell 21:51-64(2006).
RN   [27]
RP   FUNCTION, INTERACTION WITH FOXP3, AND SUBCELLULAR LOCATION.
RX   PubMed=17360565; DOI=10.1073/pnas.0700298104;
RA   Li B., Samanta A., Song X., Iacono K.T., Bembas K., Tao R., Basu S.,
RA   Riley J.L., Hancock W.W., Shen Y., Saouaf S.J., Greene M.I.;
RT   "FOXP3 interactions with histone acetyltransferase and class II
RT   histone deacetylases are required for repression.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:4571-4576(2007).
RN   [28]
RP   FUNCTION, INTERACTION WITH NR1D2, AND SUBCELLULAR LOCATION.
RX   PubMed=17996965; DOI=10.1016/j.bbamcr.2007.09.004;
RA   Wang J., Liu N., Liu Z., Li Y., Song C., Yuan H., Li Y.Y., Zhao X.,
RA   Lu H.;
RT   "The orphan nuclear receptor Rev-erbbeta recruits Tip60 and HDAC1 to
RT   regulate apolipoprotein CIII promoter.";
RL   Biochim. Biophys. Acta 1783:224-236(2008).
RN   [29]
RP   INTERACTION WITH TRIM68.
RX   PubMed=18451177; DOI=10.1158/0008-5472.CAN-07-6059;
RA   Miyajima N., Maruyama S., Bohgaki M., Kano S., Shigemura M.,
RA   Shinohara N., Nonomura K., Hatakeyama S.;
RT   "TRIM68 regulates ligand-dependent transcription of androgen receptor
RT   in prostate cancer cells.";
RL   Cancer Res. 68:3486-3494(2008).
RN   [30]
RP   INTERACTION WITH ATF2 AND CUL3, AND PROTEASOMAL DEGRADATION.
RX   PubMed=18397884; DOI=10.1074/jbc.M802030200;
RA   Bhoumik A., Singha N., O'Connell M.J., Ronai Z.A.;
RT   "Regulation of TIP60 by ATF2 modulates ATM activation.";
RL   J. Biol. Chem. 283:17605-17614(2008).
RN   [31]
RP   SUMOYLATION AT LYS-430 AND LYS-451, MUTAGENESIS OF LYS-430 AND
RP   LYS-451, SUBCELLULAR LOCATION, IDENTIFICATION BY MASS SPECTROMETRY,
RP   AND IDENTIFICATION OF KAT5-UBE2I-SENP6 COMPLEX.
RX   PubMed=17704809; DOI=10.1038/sj.onc.1210710;
RA   Cheng Z., Ke Y., Ding X., Wang F., Wang H., Wang W., Ahmed K., Liu Z.,
RA   Xu Y., Aikhionbare F., Yan H., Liu J., Xue Y., Yu J., Powell M.,
RA   Liang S., Wu Q., Reddy S.E., Hu R., Huang H., Jin C., Yao X.;
RT   "Functional characterization of TIP60 sumoylation in UV-irradiated DNA
RT   damage response.";
RL   Oncogene 27:931-941(2008).
RN   [32]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [33]
RP   FUNCTION, AND INTERACTION WITH TRIM24.
RX   PubMed=19909775; DOI=10.1016/j.bbamcr.2009.11.001;
RA   Kikuchi M., Okumura F., Tsukiyama T., Watanabe M., Miyajima N.,
RA   Tanaka J., Imamura M., Hatakeyama S.;
RT   "TRIM24 mediates ligand-dependent activation of androgen receptor and
RT   is repressed by a bromodomain-containing protein, BRD7, in prostate
RT   cancer cells.";
RL   Biochim. Biophys. Acta 1793:1828-1836(2009).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [35]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-52, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [36]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-86; SER-90 AND SER-199,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [37]
RP   INTERACTION WITH ZBTB49.
RX   PubMed=25245946; DOI=10.1093/nar/gku857;
RA   Jeon B.N., Kim M.K., Yoon J.H., Kim M.Y., An H., Noh H.J., Choi W.I.,
RA   Koh D.I., Hur M.W.;
RT   "Two ZNF509 (ZBTB49) isoforms induce cell-cycle arrest by activating
RT   transcription of p21/CDKN1A and RB upon exposure to genotoxic
RT   stress.";
RL   Nucleic Acids Res. 42:11447-11461(2014).
RN   [38]
RP   FUNCTION, AND IDENTIFICATION IN THE SWR1-LIKE COMPLEX.
RX   PubMed=24463511; DOI=10.1038/nature12922;
RA   Obri A., Ouararhni K., Papin C., Diebold M.L., Padmanabhan K.,
RA   Marek M., Stoll I., Roy L., Reilly P.T., Mak T.W., Dimitrov S.,
RA   Romier C., Hamiche A.;
RT   "ANP32E is a histone chaperone that removes H2A.Z from chromatin.";
RL   Nature 505:648-653(2014).
RN   [39]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 227-506 IN COMPLEX WITH
RP   ACETYL-COA AND ZINC IONS, AND ACETYLATION AT LYS-327.
RG   Structural genomics consortium (SGC);
RT   "The crystal structure of acetyltransferase domain of human HIV-1 TAT
RT   interacting protein in complex with acetylcoenzyme A.";
RL   Submitted (FEB-2009) to the PDB data bank.
RN   [40]
RP   STRUCTURE BY NMR OF 5-78.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of RUH-073, a pseudo chromo domain from human
RT   cDNA.";
RL   Submitted (FEB-2009) to the PDB data bank.
CC   -!- FUNCTION: Catalytic subunit of the NuA4 histone acetyltransferase
CC       complex which is involved in transcriptional activation of select
CC       genes principally by acetylation of nucleosomal histones H4 and
CC       H2A. This modification may both alter nucleosome-DNA interactions
CC       and promote interaction of the modified histones with other
CC       proteins which positively regulate transcription. This complex may
CC       be required for the activation of transcriptional programs
CC       associated with oncogene and proto-oncogene mediated growth
CC       induction, tumor suppressor mediated growth arrest and replicative
CC       senescence, apoptosis, and DNA repair. NuA4 may also play a direct
CC       role in DNA repair when recruited to sites of DNA damage. Directly
CC       acetylates and activates ATM. Component of a SWR1-like complex
CC       that specifically mediates the removal of histone H2A.Z/H2AFZ from
CC       the nucleosome. In case of HIV-1 infection, interaction with the
CC       viral Tat protein leads to KAT5 polyubiquitination and targets it
CC       to degradation. Relieves NR1D2-mediated inhibition of APOC3
CC       expression by acetylating NR1D2. Promotes FOXP3 acetylation and
CC       positively regulates its transcriptional repressor activity
CC       (PubMed:17360565). {ECO:0000269|PubMed:12776177,
CC       ECO:0000269|PubMed:14966270, ECO:0000269|PubMed:15042092,
CC       ECO:0000269|PubMed:15121871, ECO:0000269|PubMed:15310756,
CC       ECO:0000269|PubMed:16141325, ECO:0000269|PubMed:16387653,
CC       ECO:0000269|PubMed:17360565, ECO:0000269|PubMed:17996965,
CC       ECO:0000269|PubMed:19909775, ECO:0000269|PubMed:24463511}.
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + [protein]-L-lysine = CoA +
CC       [protein]-N(6)-acetyl-L-lysine. {ECO:0000269|PubMed:10096020,
CC       ECO:0000269|PubMed:12468530}.
CC   -!- SUBUNIT: Interacts with the cytoplasmic tail of APP and APBB1/FE65
CC       (By similarity). Interacts with PLA2G4A/CPLA2, EDNRA and HDAC7.
CC       Component of the NuA4 histone acetyltransferase complex which
CC       contains the catalytic subunit KAT5/TIP60 and the subunits EP400,
CC       TRRAP/PAF400, BRD8/SMAP, EPC1, DMAP1/DNMAP1, RUVBL1/TIP49, RUVBL2,
CC       ING3, actin, ACTL6A/BAF53A, MORF4L1/MRG15, MORF4L2/MRGX, MRGBP,
CC       YEATS4/GAS41, VPS72/YL1 and MEAF6. HTATTIP/TIP60, EPC1, and ING3
CC       together constitute a minimal HAT complex termed Piccolo NuA4. The
CC       NuA4 complex interacts with MYC and the adenovirus E1A protein.
CC       Interacts with ATM. Interacts with JADE1. Interacts with HIV-1
CC       Tat. Interacts with TRIM24 and TRIM68. Forms a complex with SENP6
CC       and UBE2I in response to UV irradiation. Identified in a complex
CC       with HINT1. Interacts with ATF2 and CUL3. Interacts with NR1D2
CC       (via N-terminus). Component of a SWR1-like complex. Interacts with
CC       FOXP3. Interacts with ZBTB49 (PubMed:25245946).
CC       {ECO:0000250|UniProtKB:Q99MK2, ECO:0000269|PubMed:10966108,
CC       ECO:0000269|PubMed:11262386, ECO:0000269|PubMed:11416127,
CC       ECO:0000269|PubMed:12551922, ECO:0000269|PubMed:12963728,
CC       ECO:0000269|PubMed:14966270, ECO:0000269|PubMed:15502158,
CC       ECO:0000269|PubMed:16001085, ECO:0000269|PubMed:16141325,
CC       ECO:0000269|PubMed:16835243, ECO:0000269|PubMed:17360565,
CC       ECO:0000269|PubMed:17996965, ECO:0000269|PubMed:18397884,
CC       ECO:0000269|PubMed:18451177, ECO:0000269|PubMed:19909775,
CC       ECO:0000269|PubMed:24463511, ECO:0000269|PubMed:25245946,
CC       ECO:0000269|PubMed:8607265, ECO:0000269|Ref.39}.
CC   -!- INTERACTION:
CC       P54253:ATXN1; NbExp=3; IntAct=EBI-399080, EBI-930964;
CC       Q9HC52:CBX8; NbExp=2; IntAct=EBI-399080, EBI-712912;
CC       Q96JN2-2:CCDC136; NbExp=3; IntAct=EBI-399080, EBI-10171416;
CC       Q9P2H0:CEP126; NbExp=2; IntAct=EBI-399080, EBI-473176;
CC       O43261:DLEU1; NbExp=2; IntAct=EBI-399080, EBI-710057;
CC       Q53SE7:FLJ13057; NbExp=3; IntAct=EBI-399080, EBI-10172181;
CC       Q9BZS1-1:FOXP3; NbExp=2; IntAct=EBI-399080, EBI-9695448;
CC       O95257:GADD45G; NbExp=2; IntAct=EBI-399080, EBI-448202;
CC       Q96IK5:GMCL1; NbExp=4; IntAct=EBI-399080, EBI-2548508;
CC       Q8NEA9:GMCL1P1; NbExp=3; IntAct=EBI-399080, EBI-745707;
CC       Q08379:GOLGA2; NbExp=3; IntAct=EBI-399080, EBI-618309;
CC       Q6NT76:HMBOX1; NbExp=5; IntAct=EBI-399080, EBI-2549423;
CC       Q9UKT9:IKZF3; NbExp=5; IntAct=EBI-399080, EBI-747204;
CC       Q6A162:KRT40; NbExp=3; IntAct=EBI-399080, EBI-10171697;
CC       P60411:KRTAP10-9; NbExp=3; IntAct=EBI-399080, EBI-10172052;
CC       Q17RB8:LONRF1; NbExp=3; IntAct=EBI-399080, EBI-2341787;
CC       Q9BRK4:LZTS2; NbExp=5; IntAct=EBI-399080, EBI-741037;
CC       Q99750:MDFI; NbExp=3; IntAct=EBI-399080, EBI-724076;
CC       A4D127:MEOX2; NbExp=3; IntAct=EBI-399080, EBI-10172134;
CC       Q5JR59:MTUS2; NbExp=3; IntAct=EBI-399080, EBI-742948;
CC       P10085:Myod1 (xeno); NbExp=5; IntAct=EBI-399080, EBI-4405734;
CC       Q9Y2I6:NINL; NbExp=3; IntAct=EBI-399080, EBI-719716;
CC       Q9HC29:NOD2; NbExp=2; IntAct=EBI-399080, EBI-7445625;
CC       P11926:ODC1; NbExp=5; IntAct=EBI-399080, EBI-1044287;
CC       Q8IXK0:PHC2; NbExp=3; IntAct=EBI-399080, EBI-713786;
CC       Q9NQM4:PIH1D3; NbExp=5; IntAct=EBI-399080, EBI-10239299;
CC       P29074:PTPN4; NbExp=2; IntAct=EBI-399080, EBI-710431;
CC       P35711:SOX5; NbExp=3; IntAct=EBI-399080, EBI-3505701;
CC       Q01130:SRSF2; NbExp=3; IntAct=EBI-399080, EBI-627047;
CC       Q9Y2D8:SSX2IP; NbExp=3; IntAct=EBI-399080, EBI-2212028;
CC       O75558:STX11; NbExp=5; IntAct=EBI-399080, EBI-714135;
CC       Q7Z6C6:TMCC2; NbExp=3; IntAct=EBI-399080, EBI-10177480;
CC       P04637:TP53; NbExp=3; IntAct=EBI-399080, EBI-366083;
CC       P36406:TRIM23; NbExp=3; IntAct=EBI-399080, EBI-740098;
CC       P14373:TRIM27; NbExp=3; IntAct=EBI-399080, EBI-719493;
CC       O94972:TRIM37; NbExp=3; IntAct=EBI-399080, EBI-741602;
CC       Q9NNX1:TUFT1; NbExp=3; IntAct=EBI-399080, EBI-2557363;
CC       Q15672:TWIST1; NbExp=2; IntAct=EBI-399080, EBI-1797287;
CC       O43829:ZBTB14; NbExp=3; IntAct=EBI-399080, EBI-10176632;
CC       Q96BR9:ZBTB8A; NbExp=4; IntAct=EBI-399080, EBI-742740;
CC       Q8N8E2:ZNF513; NbExp=3; IntAct=EBI-399080, EBI-10279993;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17360565}.
CC       Nucleus, nucleolus. Cytoplasm, perinuclear region. Note=Upon
CC       stimulation with EDN1, it is exported from the nucleus to the
CC       perinuclear region and UV irradiation induces translocation into
CC       punctuate subnuclear structures named nuclear bodies.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q92993-1; Sequence=Displayed;
CC       Name=2; Synonyms=PLIP;
CC         IsoId=Q92993-2; Sequence=VSP_007438;
CC       Name=3;
CC         IsoId=Q92993-3; Sequence=VSP_009104;
CC         Note=Ref.3 (no nucleotide entry) sequence is in conflict in
CC         position: 32:V->A. {ECO:0000305};
CC       Name=4;
CC         IsoId=Q92993-4; Sequence=VSP_009104, VSP_007438;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Sumoylated by UBE2I at Lys-430 and Lys-451, leading to
CC       increase of its histone acetyltransferase activity in UV-induced
CC       DNA damage response, as well as its translocation to nuclear
CC       bodies. {ECO:0000269|PubMed:17704809}.
CC   -!- PTM: Phosphorylated on Ser-86 and Ser-90; enhanced during G2/M
CC       phase. The phosphorylated form has a higher HAT activity.
CC       {ECO:0000269|PubMed:12468530}.
CC   -!- PTM: Ubiquitinated by MDM2, leading to its proteasome-dependent
CC       degradation. {ECO:0000269|PubMed:11927554}.
CC   -!- PTM: Autoacetylation at Lys-327 is required for proper function.
CC       {ECO:0000250|UniProtKB:Q9H7Z6}.
CC   -!- SIMILARITY: Belongs to the MYST (SAS/MOZ) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB02683.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/htatip/";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/HTATIPID40893ch11q13.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U74667; AAB18236.1; -; mRNA.
DR   EMBL; U40989; AAB02683.1; ALT_INIT; mRNA.
DR   EMBL; U67734; AAD00163.1; -; mRNA.
DR   EMBL; AY214165; AAO21130.1; -; Genomic_DNA.
DR   EMBL; AK304664; BAG65439.1; -; mRNA.
DR   EMBL; AP001266; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471076; EAW74427.1; -; Genomic_DNA.
DR   EMBL; CH471076; EAW74429.1; -; Genomic_DNA.
DR   EMBL; BC000166; AAH00166.3; -; mRNA.
DR   EMBL; BC064912; AAH64912.1; -; mRNA.
DR   EMBL; BC093032; AAH93032.1; -; mRNA.
DR   EMBL; BC143296; AAI43297.1; -; mRNA.
DR   EMBL; BC117167; AAI17168.1; -; mRNA.
DR   CCDS; CCDS31610.1; -. [Q92993-1]
DR   CCDS; CCDS55771.1; -. [Q92993-4]
DR   CCDS; CCDS8109.1; -. [Q92993-2]
DR   CCDS; CCDS8110.1; -. [Q92993-3]
DR   RefSeq; NP_001193762.1; NM_001206833.1. [Q92993-4]
DR   RefSeq; NP_006379.2; NM_006388.3. [Q92993-1]
DR   RefSeq; NP_874368.1; NM_182709.2. [Q92993-2]
DR   RefSeq; NP_874369.1; NM_182710.2. [Q92993-3]
DR   UniGene; Hs.397010; -.
DR   PDB; 2EKO; NMR; -; A=5-78.
DR   PDB; 2OU2; X-ray; 2.30 A; A=227-506.
DR   PDB; 4QQG; X-ray; 2.80 A; A/B/C/D/E/F/G=1-80.
DR   PDBsum; 2EKO; -.
DR   PDBsum; 2OU2; -.
DR   PDBsum; 4QQG; -.
DR   ProteinModelPortal; Q92993; -.
DR   SMR; Q92993; -.
DR   BioGrid; 115779; 225.
DR   DIP; DIP-5998N; -.
DR   IntAct; Q92993; 140.
DR   MINT; MINT-94861; -.
DR   STRING; 9606.ENSP00000340330; -.
DR   BindingDB; Q92993; -.
DR   ChEMBL; CHEMBL5750; -.
DR   DrugBank; DB01992; Coenzyme A.
DR   DrugBank; DB02039; S-Acetyl-Cysteine.
DR   GuidetoPHARMACOLOGY; 2664; -.
DR   iPTMnet; Q92993; -.
DR   PhosphoSitePlus; Q92993; -.
DR   BioMuta; KAT5; -.
DR   DMDM; 30923328; -.
DR   EPD; Q92993; -.
DR   MaxQB; Q92993; -.
DR   PaxDb; Q92993; -.
DR   PeptideAtlas; Q92993; -.
DR   PRIDE; Q92993; -.
DR   DNASU; 10524; -.
DR   Ensembl; ENST00000341318; ENSP00000340330; ENSG00000172977. [Q92993-3]
DR   Ensembl; ENST00000352980; ENSP00000344955; ENSG00000172977. [Q92993-2]
DR   Ensembl; ENST00000377046; ENSP00000366245; ENSG00000172977. [Q92993-1]
DR   Ensembl; ENST00000530446; ENSP00000434765; ENSG00000172977. [Q92993-4]
DR   GeneID; 10524; -.
DR   KEGG; hsa:10524; -.
DR   UCSC; uc001ofi.4; human. [Q92993-1]
DR   CTD; 10524; -.
DR   DisGeNET; 10524; -.
DR   GeneCards; KAT5; -.
DR   HGNC; HGNC:5275; KAT5.
DR   HPA; HPA016953; -.
DR   MIM; 601409; gene.
DR   neXtProt; NX_Q92993; -.
DR   OpenTargets; ENSG00000172977; -.
DR   PharmGKB; PA162392746; -.
DR   eggNOG; KOG2747; Eukaryota.
DR   eggNOG; COG5027; LUCA.
DR   GeneTree; ENSGT00550000074503; -.
DR   HOGENOM; HOG000182457; -.
DR   InParanoid; Q92993; -.
DR   KO; K11304; -.
DR   OMA; LDMKKLQ; -.
DR   OrthoDB; EOG091G0B73; -.
DR   PhylomeDB; Q92993; -.
DR   TreeFam; TF317619; -.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-5685938; HDR through Single Strand Annealing (SSA).
DR   Reactome; R-HSA-5685942; HDR through Homologous Recombination (HRR).
DR   Reactome; R-HSA-5693548; Sensing of DNA Double Strand Breaks.
DR   Reactome; R-HSA-5693554; Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA).
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-HSA-5693568; Resolution of D-loop Structures through Holliday Junction Intermediates.
DR   Reactome; R-HSA-5693571; Nonhomologous End-Joining (NHEJ).
DR   Reactome; R-HSA-5693579; Homologous DNA Pairing and Strand Exchange.
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-5693616; Presynaptic phase of homologous DNA pairing and strand exchange.
DR   Reactome; R-HSA-6804756; Regulation of TP53 Activity through Phosphorylation.
DR   Reactome; R-HSA-69473; G2/M DNA damage checkpoint.
DR   SignaLink; Q92993; -.
DR   SIGNOR; Q92993; -.
DR   ChiTaRS; KAT5; human.
DR   EvolutionaryTrace; Q92993; -.
DR   GeneWiki; KAT5; -.
DR   GenomeRNAi; 10524; -.
DR   PRO; PR:Q92993; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000172977; -.
DR   CleanEx; HS_KAT5; -.
DR   ExpressionAtlas; Q92993; baseline and differential.
DR   Genevisible; Q92993; HS.
DR   GO; GO:0035267; C:NuA4 histone acetyltransferase complex; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0032777; C:Piccolo NuA4 histone acetyltransferase complex; IDA:UniProtKB.
DR   GO; GO:0000812; C:Swr1 complex; IDA:UniProtKB.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0016407; F:acetyltransferase activity; TAS:Reactome.
DR   GO; GO:0050681; F:androgen receptor binding; NAS:UniProtKB.
DR   GO; GO:0004402; F:histone acetyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0070491; F:repressing transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB.
DR   GO; GO:1904837; P:beta-catenin-TCF complex assembly; TAS:Reactome.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; IDA:UniProtKB.
DR   GO; GO:0006978; P:DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator; IDA:UniProtKB.
DR   GO; GO:0000729; P:DNA double-strand break processing; TAS:Reactome.
DR   GO; GO:0006260; P:DNA replication; TAS:Reactome.
DR   GO; GO:0000731; P:DNA synthesis involved in DNA repair; TAS:Reactome.
DR   GO; GO:0006302; P:double-strand break repair; IMP:UniProtKB.
DR   GO; GO:0006303; P:double-strand break repair via nonhomologous end joining; TAS:Reactome.
DR   GO; GO:0016573; P:histone acetylation; IDA:UniProtKB.
DR   GO; GO:0032703; P:negative regulation of interleukin-2 production; IDA:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IMP:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL.
DR   GO; GO:1901985; P:positive regulation of protein acetylation; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; IMP:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0040008; P:regulation of growth; IEA:UniProtKB-KW.
DR   GO; GO:1901796; P:regulation of signal transduction by p53 class mediator; TAS:Reactome.
DR   GO; GO:0010212; P:response to ionizing radiation; IDA:UniProtKB.
DR   GO; GO:0000732; P:strand displacement; TAS:Reactome.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   InterPro; IPR016181; Acyl_CoA_acyltransferase.
DR   InterPro; IPR000953; Chromo/chromo_shadow_dom.
DR   InterPro; IPR016197; Chromodomain-like.
DR   InterPro; IPR002717; HAT_MYST-type.
DR   InterPro; IPR025995; Tudor-knot.
DR   Pfam; PF01853; MOZ_SAS; 1.
DR   Pfam; PF11717; Tudor-knot; 1.
DR   SMART; SM00298; CHROMO; 1.
DR   SUPFAM; SSF54160; SSF54160; 1.
DR   SUPFAM; SSF55729; SSF55729; 1.
DR   PROSITE; PS51726; MYST_HAT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Acyltransferase;
KW   Alternative splicing; Chromatin regulator; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Growth regulation;
KW   Host-virus interaction; Isopeptide bond; Metal-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation; Transferase; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN         1    513       Histone acetyltransferase KAT5.
FT                                /FTId=PRO_0000051580.
FT   DOMAIN      227    504       MYST-type HAT. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01063}.
FT   ZN_FING     260    285       C2HC MYST-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01063, ECO:0000305|Ref.39}.
FT   REGION      368    513       Interaction with ATF2.
FT                                {ECO:0000269|PubMed:18397884}.
FT   REGION      370    372       Acetyl-CoA binding. {ECO:0000269|Ref.39}.
FT   REGION      377    383       Acetyl-CoA binding. {ECO:0000269|Ref.39}.
FT   ACT_SITE    403    403       Proton donor/acceptor.
FT                                {ECO:0000250|UniProtKB:Q9H7Z6}.
FT   BINDING     407    407       Acetyl-CoA. {ECO:0000269|Ref.39}.
FT   BINDING     416    416       Acetyl-CoA.
FT                                {ECO:0000250|UniProtKB:Q9H7Z6}.
FT   MOD_RES      52     52       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      86     86       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:12468530}.
FT   MOD_RES      90     90       Phosphoserine; by CDK1.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000269|PubMed:12468530}.
FT   MOD_RES     199    199       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     327    327       N6-acetyllysine; by autocatalysis.
FT                                {ECO:0000269|Ref.39}.
FT   CROSSLNK    430    430       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000269|PubMed:17704809}.
FT   CROSSLNK    451    451       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO).
FT                                {ECO:0000269|PubMed:17704809}.
FT   VAR_SEQ       4      4       V -> VVSPVPGAGRREPGEVGRARGPPVADPGVALSPQ
FT                                (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:12801643,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_009104.
FT   VAR_SEQ      96    147       Missing (in isoform 2 and isoform 4).
FT                                {ECO:0000303|PubMed:11416127,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_007438.
FT   VARIANT      78     78       P -> T (in dbSNP:rs11541271).
FT                                /FTId=VAR_059456.
FT   MUTAGEN      86     86       S->A: Reduces phosphorylation. Abolishes
FT                                phosphorylation; when associated with A-
FT                                90. Reduced HAT activity.
FT                                {ECO:0000269|PubMed:12468530}.
FT   MUTAGEN      90     90       S->A: Reduces phosphorylation. Abolishes
FT                                phosphorylation; when associated with A-
FT                                86. Reduced HAT activity.
FT                                {ECO:0000269|PubMed:12468530}.
FT   MUTAGEN     254    254       L->A: Does not affect phosphorylation;
FT                                when associated with A-257.
FT                                {ECO:0000269|PubMed:12468530}.
FT   MUTAGEN     257    257       L->A: Does not affect phosphorylation;
FT                                when associated with A-254.
FT                                {ECO:0000269|PubMed:12468530}.
FT   MUTAGEN     380    380       G->A: Loss of function. Does not affect
FT                                phosphorylation.
FT                                {ECO:0000269|PubMed:12468530}.
FT   MUTAGEN     430    430       K->R: Abrogates sumoylation.
FT                                {ECO:0000269|PubMed:17704809}.
FT   MUTAGEN     451    451       K->R: Abrogates sumoylation.
FT                                {ECO:0000269|PubMed:17704809}.
FT   CONFLICT    382    382       G -> R (in Ref. 1; AAB18236/AAB02683).
FT                                {ECO:0000305}.
FT   HELIX         4      6       {ECO:0000244|PDB:4QQG}.
FT   STRAND       12     15       {ECO:0000244|PDB:4QQG}.
FT   STRAND       28     35       {ECO:0000244|PDB:4QQG}.
FT   STRAND       37     40       {ECO:0000244|PDB:4QQG}.
FT   STRAND       42     47       {ECO:0000244|PDB:4QQG}.
FT   HELIX        52     54       {ECO:0000244|PDB:4QQG}.
FT   STRAND       56     58       {ECO:0000244|PDB:4QQG}.
FT   HELIX        60     62       {ECO:0000244|PDB:4QQG}.
FT   HELIX        65     67       {ECO:0000244|PDB:2EKO}.
FT   STRAND      235    237       {ECO:0000244|PDB:2OU2}.
FT   STRAND      240    242       {ECO:0000244|PDB:2OU2}.
FT   HELIX       252    254       {ECO:0000244|PDB:2OU2}.
FT   STRAND      260    262       {ECO:0000244|PDB:2OU2}.
FT   TURN        264    266       {ECO:0000244|PDB:2OU2}.
FT   STRAND      269    271       {ECO:0000244|PDB:2OU2}.
FT   HELIX       273    282       {ECO:0000244|PDB:2OU2}.
FT   STRAND      289    296       {ECO:0000244|PDB:2OU2}.
FT   STRAND      299    305       {ECO:0000244|PDB:2OU2}.
FT   TURN        306    308       {ECO:0000244|PDB:2OU2}.
FT   HELIX       310    321       {ECO:0000244|PDB:2OU2}.
FT   TURN        328    331       {ECO:0000244|PDB:2OU2}.
FT   STRAND      336    345       {ECO:0000244|PDB:2OU2}.
FT   STRAND      348    360       {ECO:0000244|PDB:2OU2}.
FT   STRAND      365    368       {ECO:0000244|PDB:2OU2}.
FT   STRAND      370    372       {ECO:0000244|PDB:2OU2}.
FT   HELIX       374    376       {ECO:0000244|PDB:2OU2}.
FT   HELIX       381    395       {ECO:0000244|PDB:2OU2}.
FT   STRAND      400    402       {ECO:0000244|PDB:2OU2}.
FT   HELIX       408    425       {ECO:0000244|PDB:2OU2}.
FT   HELIX       441    448       {ECO:0000244|PDB:2OU2}.
FT   HELIX       452    461       {ECO:0000244|PDB:2OU2}.
FT   STRAND      469    474       {ECO:0000244|PDB:2OU2}.
FT   HELIX       497    499       {ECO:0000244|PDB:2OU2}.
SQ   SEQUENCE   513 AA;  58582 MW;  63724F5E10B957D5 CRC64;
     MAEVGEIIEG CRLPVLRRNQ DNEDEWPLAE ILSVKDISGR KLFYVHYIDF NKRLDEWVTH
     ERLDLKKIQF PKKEAKTPTK NGLPGSRPGS PEREVPASAQ ASGKTLPIPV QITLRFNLPK
     EREAIPGGEP DQPLSSSSCL QPNHRSTKRK VEVVSPATPV PSETAPASVF PQNGAARRAV
     AAQPGRKRKS NCLGTDEDSQ DSSDGIPSAP RMTGSLVSDR SHDDIVTRMK NIECIELGRH
     RLKPWYFSPY PQELTTLPVL YLCEFCLKYG RSLKCLQRHL TKCDLRHPPG NEIYRKGTIS
     FFEIDGRKNK SYSQNLCLLA KCFLDHKTLY YDTDPFLFYV MTEYDCKGFH IVGYFSKEKE
     STEDYNVACI LTLPPYQRRG YGKLLIEFSY ELSKVEGKTG TPEKPLSDLG LLSYRSYWSQ
     TILEILMGLK SESGERPQIT INEISEITSI KKEDVISTLQ YLNLINYYKG QYILTLSEDI
     VDGHERAMLK RLLRIDSKCL HFTPKDWSKR GKW
//
